Stevens-Johnson Syndrome: Clinical Trials

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	1	Terminated 1
Phase 2	1	Terminated 1

Follow Stevens-Johnson Syndrome: new trials by email Literature Review of Stevens-Johnson Syndrome trials Research Report on Stevens-Johnson Syndrome

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis Palifermin - Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome	Phase 1 / Phase 2	Terminated	Brett King	1	2010-10-01	2016-11-30

Broader conditions

Chemically-Induced Disorders (1)  ·  Dermatitis (1)  ·  Drug Eruptions (1)  ·  Drug Hypersensitivity (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Erythema (1)  ·  Erythema Multiforme (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)  ·  Immune System Diseases (1)  ·  Mouth Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Stomatitis (1)

Interventions

Fibroblast Growth Factor 7 (1)

Sponsors

Brett King (1)

Countries

United States (1)